Literature DB >> 8813947

Clostridium difficile infection of the gut.

A P Dodson1, S P Borriello.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8813947      PMCID： PMC500563          DOI： 10.1136/jcp.49.7.529

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  37 in total

1.  Acute enterocolitis following partial gastrectomy.

Authors:  P DAWSON-EDWARDS; D M MORRISSEY
Journal:  Br J Surg       Date:  1955-05       Impact factor: 6.939

2.  Identification of Clostridium difficile as a cause of pseudomembranous colitis.

Authors:  R H George; J M Symonds; F Dimock; J D Brown; Y Arabi; N Shinagawa; M R Keighley; J Alexander-Williams; D W Burdon
Journal:  Br Med J       Date:  1978-03-18

Review 3.  Antibiotic and pseudomembranous colitis.

Authors:  S P Borriello; H E Larson
Journal:  J Antimicrob Chemother       Date:  1981-06       Impact factor: 5.790

4.  Treatment of recurrent Clostridium difficile colitis with vancomycin and Saccharomyces boulardii.

Authors:  C M Surawicz; L V McFarland; G Elmer; J Chinn
Journal:  Am J Gastroenterol       Date:  1989-10       Impact factor: 10.864

Review 5.  Bacteremia due to Clostridium difficile: case report and review of extraintestinal C. difficile infections.

Authors:  R J Feldman; M Kallich; M P Weinstein
Journal:  Clin Infect Dis       Date:  1995-06       Impact factor: 9.079

6.  Evaluation of three commercial enzyme immunoassay kits for detecting faecal Clostridium difficile toxins.

Authors:  S A Arrow; L Croese; R A Bowman; T V Riley
Journal:  J Clin Pathol       Date:  1994-10       Impact factor: 3.411

7.  Transient expression of RhoA, -B, and -C GTPases in HeLa cells potentiates resistance to Clostridium difficile toxins A and B but not to Clostridium sordellii lethal toxin.

Authors:  M Giry; M R Popoff; C von Eichel-Streiber; P Boquet
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

8.  Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile.

Authors:  D M Lyerly; L A Barroso; T D Wilkins; C Depitre; G Corthier
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

9.  Effects of Clostridium difficile toxins given intragastrically to animals.

Authors:  D M Lyerly; K E Saum; D K MacDonald; T D Wilkins
Journal:  Infect Immun       Date:  1985-02       Impact factor: 3.441

10.  Closing in on the toxic domain through analysis of a variant Clostridium difficile cytotoxin B.

Authors:  C von Eichel-Streiber; D Meyer zu Heringdorf; E Habermann; S Sartingen
Journal:  Mol Microbiol       Date:  1995-07       Impact factor: 3.501
View more
  3 in total

1.  Evaluation of a new enzyme immunoassay for Clostridium difficile toxin A.

Authors:  S O Vargas; D Horensky; A B Onderdonk
Journal:  J Clin Pathol       Date:  1997-12       Impact factor: 3.411

2.  Clostridium difficile MazF toxin exhibits selective, not global, mRNA cleavage.

Authors:  Francesca P Rothenbacher; Motoo Suzuki; Jennifer M Hurley; Thomas J Montville; Thomas J Kirn; Ming Ouyang; Nancy A Woychik
Journal:  J Bacteriol       Date:  2012-04-27       Impact factor: 3.490

3.  Clostridium difficile modulates host innate immunity via toxin-independent and dependent mechanism(s).

Authors:  Nazila V Jafari; Sarah A Kuehne; Clare E Bryant; Mamoun Elawad; Brendan W Wren; Nigel P Minton; Elaine Allan; Mona Bajaj-Elliott
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.